Xlife Sciences AG
Develops and commercializes early-stage life sciences research projects.
XLS | SW
Overview
Corporate Details
- ISIN(s):
- CH0461929603 (+1 more)
- LEI:
- 984500AH590BE88BB517
- Country:
- Switzerland
- Address:
- Talacker 35, 8001 Zürich
Description
Xlife Sciences AG is a life sciences company that specializes in the value development and commercialization of early-stage research projects. The company identifies promising technologies from universities and other research institutions, acting as an incubator and accelerator to bridge the gap between academic research and healthcare markets. Its operations are focused on four core areas: technology platforms, biotechnologies and therapies, medical technology (health technology), and the application of artificial intelligence in life sciences and digital health. The primary objective is to develop solutions that address high unmet medical needs and improve quality of life.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-06-16 16:00 |
Strategic Collaboration Between Xlife Sciences AG, Huraypositive Corp., and Onc…
|
English | HTML • 9.8 KB | ||
| 2025-06-16 02:00 |
Strategic Collaboration Between Xlife Sciences AG, Huraypositive Corp., and Onc…
|
English | HTML • 12.3 KB | ||
| 2025-06-16 02:00 |
Strategische Zusammenarbeit zwischen Xlife Sciences AG, Huraypositive Corp. und…
|
German | HTML • 13.4 KB | ||
| 2025-06-13 17:42 |
Strategic Alliance Between Xlife Sciences AG, JIPYONG LLC and JIPYONG IP to Acc…
|
English | HTML • 9.0 KB | ||
| 2025-06-13 02:00 |
Strategic Alliance Between Xlife Sciences AG, JIPYONG LLC and JIPYONG IP to Acc…
|
English | HTML • 11.4 KB | ||
| 2025-06-13 02:00 |
Strategische Allianz zwischen Xlife Sciences AG, JIPYONG LLC und JIPYONG IP sol…
|
German | HTML • 12.9 KB | ||
| 2025-05-07 07:00 |
Xlife Sciences AG Announces Strategic Collaboration between Portfolio Company F…
|
English | HTML • 9.9 KB | ||
| 2025-05-05 07:00 |
Xlife Sciences AG confirms sustainable value development and strategic scaling …
|
English | HTML • 5.4 KB | ||
| 2025-04-25 07:00 |
Xlife Sciences AG publishes 2024 Annual Report: Strategic Expansion, Technologi…
|
English | HTML • 7.2 KB | ||
| 2025-04-23 07:00 |
From Lab to Unicorn: Xlife Sciences AG Portfolio Company VERAXA Biotech AG to m…
|
English | HTML • 7.3 KB | ||
| 2024-12-24 18:35 |
Xlife Sciences AG Announces Potential Acquisition of Portfolio Company FUSE-AI …
|
English | HTML • 8.3 KB | ||
| 2024-12-23 18:35 |
Xlife Sciences AG Announces Potential Acquisition of Portfolio Company FUSE-AI …
|
English | HTML • 8.3 KB | ||
| 2024-12-23 01:00 |
Xlife Sciences AG Announces Potential Acquisition of Portfolio Company FUSE-AI …
|
English | HTML • 6.8 KB | ||
| 2024-12-23 01:00 |
Xlife Sciences AG kündigt die potenzielle Übernahme des Portfoliounternehmens F…
|
German | HTML • 10.8 KB | ||
| 2024-12-20 07:00 |
Xlife Sciences AG Publishes 2023 ESG Report: A Continued Commitment to Sustaina…
|
English | HTML • 12.7 KB |
Automate Your Workflow. Get a real-time feed of all Xlife Sciences AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Xlife Sciences AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Xlife Sciences AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-06-15 | N/A | Executive member | Buy | None | 6,000.00 CHF |
| 2022-06-15 | N/A | Executive member | Buy | None | 3,000.00 CHF |
| 2022-06-14 | N/A | Executive member | Buy | None | 15,500.00 CHF |
| 2022-06-10 | N/A | Executive member | Buy | None | 6,728.90 CHF |
| 2022-06-07 | N/A | Executive member | Buy | None | 34,800.00 CHF |
| 2022-06-03 | N/A | Executive member | Buy | None | 3,540.00 CHF |
| 2022-05-24 | N/A | Executive member | Buy | None | 3,400.00 CHF |
| 2022-05-17 | N/A | Executive member | Buy | None | 10,794.20 CHF |
| 2022-05-13 | N/A | Executive member | Buy | None | 3,690.00 CHF |
| 2022-05-10 | N/A | Executive member | Buy | None | 1,935.00 CHF |
Peer Companies
